A detailed history of Midwest Professional Planners, Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Midwest Professional Planners, Ltd. holds 17,700 shares of ABBV stock, worth $2.96 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
17,700
Previous 16,473 7.45%
Holding current value
$2.96 Million
Previous $2.55 Million 26.29%
% of portfolio
1.14%
Previous 1.05%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $196,099 - $223,436
1,227 Added 7.45%
17,700 $3.22 Million
Q4 2023

Feb 15, 2024

SELL
$137.6 - $154.97 $367,529 - $413,924
-2,671 Reduced 13.95%
16,473 $2.55 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $310,596 - $359,561
2,325 Added 13.82%
19,144 $2.85 Million
Q2 2023

Aug 07, 2023

BUY
$132.51 - $164.9 $304,110 - $378,445
2,295 Added 15.8%
16,819 $2.27 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $146,923 - $169,204
1,016 Added 7.52%
14,524 $2.31 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $142,597 - $171,011
1,031 Added 8.26%
13,508 $2.18 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $117,299 - $134,534
874 Added 7.53%
12,477 $1.68 Million
Q2 2022

Aug 09, 2022

BUY
$137.62 - $174.96 $82,296 - $104,626
598 Added 5.43%
11,603 $1.78 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $82,223 - $102,016
623 Added 6.0%
11,005 $1.78 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $23,097 - $29,224
215 Added 2.11%
10,382 $1.41 Million
Q3 2021

Nov 08, 2021

BUY
$106.4 - $120.78 $28,302 - $32,127
266 Added 2.69%
10,167 $1.1 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $502,377 - $559,677
4,775 Added 93.15%
9,901 $1.12 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $447,562 - $492,712
-4,375 Reduced 46.05%
5,126 $391,000
Q4 2020

Mar 11, 2021

BUY
$80.49 - $108.67 $39,440 - $53,248
490 Added 5.44%
9,501 $1.02 Million
Q3 2020

Nov 06, 2020

BUY
$85.91 - $100.83 $70,102 - $82,277
816 Added 9.96%
9,011 $789,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $225,172 - $301,314
3,069 Added 59.87%
8,195 $805,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $13,287 - $20,144
206 Added 4.19%
5,126 $391,000
Q4 2019

Feb 11, 2020

SELL
$72.13 - $90.25 $1,731 - $2,166
-24 Reduced 0.49%
4,920 $436,000
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $123,503 - $148,486
1,961 Added 65.74%
4,944 $374,000
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $4,599 - $5,878
-70 Reduced 2.29%
2,983 $217,000
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $476,879 - $561,263
-6,182 Reduced 66.94%
3,053 $246,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $4,515 - $5,568
-58 Reduced 0.62%
9,235 $851,000
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $428,012 - $475,815
4,814 Added 107.48%
9,293 $879,000
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $5,745 - $6,798
64 Added 1.45%
4,479 $415,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $28,063 - $37,579
305 Added 7.42%
4,415 $418,000
Q4 2017

Feb 13, 2018

BUY
$89.56 - $98.21 $368,091 - $403,643
4,110
4,110 $397,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Midwest Professional Planners, Ltd. Portfolio

Follow Midwest Professional Planners, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Midwest Professional Planners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Midwest Professional Planners, Ltd. with notifications on news.